Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 1, 2012, Pages 185-190

  Schwarz, Julie K ^a,b   Siegel, Barry A ^a,b   Dehdashti, Farrokh ^a,b   Grigsby, Perry W ^a,b,c  

^a USA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; FDG PET; Metabolic response

Indexed keywords

BRACHYTHERAPY; CERVICAL CANCERS; CHI-SQUARE TESTS; CONCURRENT CHEMOTHERAPY; DEFINITIVE RADIOTHERAPY; EXTERNAL RADIOTHERAPY; F-FLUORODEOXYGLUCOSE; FAILURE PATTERNS; FDG-PET; LOCAL FAILURE; LOCAL RECURRENCE; LYMPH NODE; METABOLIC RESPONSE; PATTERNS OF FAILURE; PELVIC LYMPH NODES; PRE-TREATMENT; PROGRESSIVE DISEASE; TREATMENT FAILURE;

BODY FLUIDS; CHEMOTHERAPY; METABOLISM; POSITRON EMISSION TOMOGRAPHY; STATISTICAL TESTS;

RADIOTHERAPY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMPLETE METABOLIC RESPONSE; CONFERENCE PAPER; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; METABOLISM; PARTIAL METABOLIC RESPONSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT FAILURE; TREATMENT RESPONSE; UTERINE CERVIX; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADENOCARCINOMA, CLEAR CELL; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TREATMENT FAILURE; UTERINE CERVICAL NEOPLASMS; UTERUS; YOUNG ADULT;

EID: 84859844971     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.05.053     Document Type: Conference Paper

References (14)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. Falasca M. PI3K/Akt signalling pathway specific inhibitors: A novel strategy to sensitize cancer cells to anti-cancer drugs. Available at: www.seer.cancer.gov/csr/1975-2002/. Accessed February 16, 2011.
3. P.G. Rose, B.N. Bundy, and E.B. Watkins Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1999 1144 1153
4. P.J. Eifel, K. Winter, and M. Morris Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 J Clin Oncol 22 2004 872 880
5. G. Sommers, P.W. Grigsby, and C.A. Perez Outcome of recurrent cervical carcinoma following definitive irradiation Gynecol Oncol 35 1989 150 155
6. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 2001 3745 3749
7. J.K. Schwarz, B.A. Siegel, and F. Dehdashti Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JAMA 298 2007 2289 2295
8. P.W. Grigsby, B.A. Siegel, and F. Dehdashti Posttherapy surveillance monitoring of cervical cancer by FDG-PET Int J Radiat Oncol Biol Phys 55 2003 907 913
9. J.D. Wright, F. Dehdashti, and T.J. Herzog Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose- positron emission tomography Cancer 104 2005 2484 2491
10. R.G. Stock, A.S. Chen, and K. Karasek Patterns of spread in node-positive cervical cancer: The relationship between local control and distant metastases Cancer J Sci Am 2 1996 256 262
11. M. Sasaoka, N. Fuwa, and A. Asano Patterns of failure in carcinoma of the uterine cervix treated with definitive radiotherapy alone Am J Clin Oncol 24 2001 586 590
12. T.K. Park, J.Y. Kwon, and S.W. Kim Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma Int J Clin Oncol 9 2004 120 124
13. B.M. Beadle, A. Jhingran, and M. Salehpour Cervix regression and motion during the course of external beam chemoradiation for cervical cancer Int J Radiat Oncol Biol Phys 73 2009 235 241
14. H. Schoder, M. Fury, and N. Lee PET monitoring of therapy response in head and neck squamous cell carcinoma J Nucl Med 50 Suppl. 1 2009 74S 88S